1	15 receive an experimental/investigational agent vaccine drug biologic device blood product or medication within 28 day prior to vaccination in this study or expect to receive an experimental/investigational agent within the follow-up time period 28 day after the last vaccination in this study|vaccine[49,56]|||||||28 day[113,119]|||11094|11094|vaccine
